-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Clinical testing service> 8 years
Cooperate with Class III A/Tumor Specialty Hospitals> 500
Accumulate the Chinese tumor NGS genome database> 420,000 cases
Cumulative published SCI articles>260
Cumulative Impact Factor (IF)>1700 points
The self-developed "EGFR/ALK/ROS1/BRAF/KRAS/HER2 gene mutation detection kit (reversible terminal termination sequencing method)" (National Machinery Note 20183400408) was approved by the NMPA in September 2018, and comprehensively guides lung cancer targeted drugs , The sensitivity is as high as 1%
.